LWA
IDXX icon

Lantern Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Lantern Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-330
Closed -$223K – 179
2025
Q4 		$223K Sell
330
-50
-13% -$34.1K 0.12% 147
2025
Q3 		$211K Buy
+380
New +$231K 0.11% 146
2024
Q4 		– Sell
-550
Closed -$278K – 140
2024
Q3 		$278K Hold
550
– – 0.19% 101
2024
Q2 		$268K Sell
550
-50
-8% -$25.1K 0.19% 98
2024
Q1 		$324K Buy
600
+50
+9% +$27.3K 0.23% 96
2023
Q4 		$305K Buy
+550
New +$258K 0.24% 88

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lantern Wealth Advisors's IDXX Position: Q1 2026 in Review

Lantern Wealth Advisors sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 330 shares — an estimated $223K sold.

Lantern Wealth Advisors first reported a position in IDXX in Q4 2023 and held it in 6 quarters. The position peaked at $324K in Q1 2024. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Lantern Wealth Advisors reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Lantern Wealth Advisors sold 330 Idexx Laboratories shares in Q1 2026, an estimated $223K.
  • Lantern Wealth Advisors first reported a position in Idexx Laboratories in Q4 2023 and held it in 6 quarters.
  • Lantern Wealth Advisors's Idexx Laboratories position peaked at $324K in Q1 2024.
  • 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Lantern Wealth Advisors's 13F filing for Q1 2026, filed 13 May 2026.